COLECCHIA, MAURIZIO
 Distribuzione geografica
Continente #
AS - Asia 3.172
NA - Nord America 1.509
EU - Europa 1.138
SA - Sud America 1.050
AF - Africa 57
OC - Oceania 4
Totale 6.930
Nazione #
US - Stati Uniti d'America 1.411
SG - Singapore 1.187
CN - Cina 987
BR - Brasile 890
HK - Hong Kong 546
SE - Svezia 335
IT - Italia 259
VN - Vietnam 244
RU - Federazione Russa 170
DE - Germania 107
FI - Finlandia 58
AR - Argentina 57
GB - Regno Unito 44
MX - Messico 44
AT - Austria 40
EC - Ecuador 39
IN - India 36
BD - Bangladesh 34
CA - Canada 34
ID - Indonesia 28
PL - Polonia 26
CO - Colombia 20
ES - Italia 20
IQ - Iraq 20
ZA - Sudafrica 20
TR - Turchia 18
JP - Giappone 16
NL - Olanda 16
UZ - Uzbekistan 14
FR - Francia 12
VE - Venezuela 12
UA - Ucraina 10
PE - Perù 9
CL - Cile 8
PY - Paraguay 8
RO - Romania 8
TN - Tunisia 8
KE - Kenya 7
PK - Pakistan 7
IE - Irlanda 6
JO - Giordania 6
LT - Lituania 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
SA - Arabia Saudita 5
KZ - Kazakistan 4
PA - Panama 4
PT - Portogallo 4
SN - Senegal 4
UY - Uruguay 4
AL - Albania 3
AU - Australia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GR - Grecia 3
NI - Nicaragua 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
ET - Etiopia 2
IR - Iran 2
JM - Giamaica 2
LB - Libano 2
OM - Oman 2
AO - Angola 1
BE - Belgio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
LV - Lettonia 1
MK - Macedonia 1
NP - Nepal 1
NR - Nauru 1
QA - Qatar 1
TG - Togo 1
TT - Trinidad e Tobago 1
Totale 6.930
Città #
Hong Kong 546
Singapore 496
Dallas 285
Shanghai 282
Hefei 182
Lawrence 150
Princeton 150
Ashburn 140
Beijing 113
Moscow 106
Ho Chi Minh City 102
Milan 96
New York 94
São Paulo 69
Los Angeles 52
Hanoi 50
Boardman 45
Rio de Janeiro 45
Helsinki 39
Nuremberg 37
Brasília 24
Guangzhou 24
Belo Horizonte 19
Porto Alegre 19
Warsaw 19
Munich 17
Rome 17
Phoenix 15
Shenzhen 14
Curitiba 13
Lappeenranta 13
Montreal 13
Salvador 13
Guayaquil 12
Santa Clara 12
Tashkent 12
Brooklyn 11
Dhaka 11
Quito 11
Tokyo 11
Vienna 11
Atlanta 10
Baghdad 10
Chicago 10
Goiânia 10
Johannesburg 10
Osasco 10
Rozzano 10
Ankara 9
Da Nang 9
Denver 9
Fortaleza 9
Juiz de Fora 9
London 9
Naples 9
Orem 9
Thái Bình 9
Buffalo 8
Caxias do Sul 8
Chennai 8
Guarulhos 8
Haiphong 8
Jiaxing 8
Nova Iguaçu 8
Querétaro 8
Stockholm 8
The Dalles 8
Bogotá 7
Buenos Aires 7
Can Tho 7
Cesano Boscone 7
Cluj-Napoca 7
Jakarta 7
Nairobi 7
Piracicaba 7
Poplar 7
Ribeirão Preto 7
Amman 6
Betim 6
Boston 6
Campo Grande 6
Dublin 6
Frankfurt am Main 6
Gravataí 6
Houston 6
Kassel 6
Manchester 6
Mexico City 6
Thái Nguyên 6
Turin 6
Turku 6
Asunción 5
Biên Hòa 5
Blumenau 5
Charlotte 5
Columbus 5
Erbil 5
Hangzhou 5
Hải Dương 5
Istanbul 5
Totale 3.820
Nome #
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 161
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 101
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 89
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 82
A case report of myoid gonadal stromal tumor treated with testis sparing surgery 76
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies 75
A Combination of Cisplatin and 5-Fluorouracil With a Taxane in Patients Who Underwent Lymph Node Dissection for Nodal Metastases From Squamous Cell Carcinoma of the Penis: Treatment Outcome and Survival Analyses in Neoadjuvant and Adjuvant Settings 72
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 71
Total embedding of spermatic cord and hilar soft tissue in orchiectomy for seminoma: does the extensive sampling improve pathologic risk factors? 70
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 70
Leiomyoadenomatoid tumours of the epididymis: A new case report and review of the literature 68
Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma: Results of the BONSAI Trial for the Italian Network for Research in Urologic-Oncology (Meet-URO 2 Study) 66
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study 65
Sex cord stromal tumors and tumors of the paratestis: new and old entities in a landscape of rare tumors 64
[The treatment of early-stage germ cell tumors of the testis (GCTT)]. [Il trattamento dei Tumori Germinali del Testicolo (TGT) in fase iniziale.] 64
Atypical pleomorphic epithelioid angiomyolipoma localized to the pelvis: a case report and review of the literature 64
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 64
Role of Follicle-stimulating Hormone, Inhibin B, and Anti-Müllerian Hormone in Predicting Sperm Retrieval from Men with Nonobstructive Azoospermia Undergoing Microdissection Testicular Sperm Extraction: A Systematic Review and Meta-analysis 63
Re: Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-Invasive Bladder Carcinoma with Variant Histologies 61
A Case of Plasmacytoid Variant of Bladder Cancer With a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature. 60
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 57
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer 57
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies 55
Anti-Müllerian hormone predicts positive sperm retrieval in men with idiopathic non-obstructive azoospermia-findings from a multi-centric cross-sectional study 55
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty 55
The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer 55
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 54
Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma 53
Benign glomus tumor of the urinary bladder. 51
Pathology of testicular and penile neoplasms 51
Penile cancer 50
Teratoma With Somatic-Type Malignant Components in Germ Cell Tumors of the Testis: A Clinicopathologic Analysis of 40 Cases With Outcome Correlation 49
An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis 49
Brentuximab Vedotin in CD30-Expressing Germ Cell Tumors After Chemotherapy Failure 48
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System 48
Carney triad: case report and molecular analysis of gastric tumor 48
The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification 47
CD 57 Antigen 47
A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient 47
SOX2 and PRAME in the “reprogramming” of seminoma cells 47
Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients 46
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 45
Clinical Outcome in Testicular Sex Cord Stromal Tumors: Testis Sparing vs Radical Orchiectomy and Management of Advanced Disease 45
Treatment of Carcinoma In Situ of the Glans Penis With Topical Imiquimod Followed by Carbon Dioxide Laser Excision 45
Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism 45
Cystic Clear Cell Renal Cell Carcinoma: A Morphological and Molecular Reappraisal 45
Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): An open-label, single-arm, phase II study 44
Frequent mutation and nuclear localization of β-catenin in sertoli cell tumors of the testis 44
Understanding the somatic-type malignant differentiation in male germ-cell cancer: A work in progress. Response to the article by Spiess et al., Malignant transformation of testicular teratoma: A chemoresistant phenotype. Urol Oncol 2008;26:595-9 43
Immunohistochemistry to Enhance Prognostic Allocation and Guide Decision-Making of Patients With Advanced Urothelial Cancer Receiving First-Line Chemotherapy 43
Detection Rate of Anterior Prostate Cancer in 226 Patients Submitted to Initial and Repeat Transperineal Biopsy 43
Prostatic and urothelial metastasis in the same lymph node: a case report 43
Clinical Outcomes in Clinical N0 Squamous Cell Carcinoma of the Penis According to Nodal Management: Early, Delayed or Selective (following Dynamic Sentinel Node Biopsy) Inguinal Lymph-Node Dissection 43
FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type 42
Renal tumor biopsy in patients with cT1b-T4-M0 disease susceptible to radical nephrectomy: analysis of safety, accuracy and clinical impact on definitive management 42
p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors 42
Prediction of grade reclassification of prostate cancer patients on active surveillance through the combination of a three-mirna signature and selected clinical variables 42
Prognostic Effect of FGFR Mutations or Gene Fusions in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Results from a Large, Single-institution Cohort 41
Assessment and reporting of pathological findings of penile specimens 41
Carcinoma tiroideo iperfunzionante.Descrizione di un caso. 41
Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 study 40
Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration 40
Relationship between lymph node ratio and cancer-specific survival in a contemporary series of patients with penile cancer and lymph node metastases 40
Myomelanocytic tumor of the thigh 40
Lack of SYT-SSX fusion transcripts in malignant peripheral nerve sheath tumors on RT-PCR analysis of 34 archival cases 40
Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma 40
Association of Androgen Receptor Expression on Tumor Cells and PD-L1 Expression in Muscle-Invasive and Metastatic Urothelial Carcinoma: Insights for Clinical Research 40
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer 39
Erratum to 'Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations'[European Urology Oncology 2 (2019) 277-285 38
Immunophenotypic and genotypic analysis of a case of primary peripheral primitive neuroectodermal tumour (pPNET) of the urinary bladder 38
pT1 penile squamous cell carcinoma: a clinicopathologic study of 56 cases treated by CO2 laser therapy 38
Integrative transcriptomic analysis reveals distinctive molecular traits and novel subtypes of collecting duct carcinoma 38
First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study 37
Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference 37
Salivary duct carcinoma of the parotid gland. Report of a case with cytologic and Immunocytochemical findings on fine needle aspiration biopsy 37
Dual modulation of MCL-1 and mTOR determines the response to sunitinib 37
Malaric placentas A quantitative study and clinicopathological correlations 37
Chordoma: natural history and results in 28 patients treated at a single institution 37
Large cell calcifying Sertoli cell tumour: molecular and immunohistochemical assessment of a series comprising non-metastasising and metastasising neoplasms 36
TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis 36
Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure 36
Panitumumab Treatment for Advanced Penile Squamous Cell Carcinoma When Surgery and Chemotherapy Have Failed 36
The Relationship between Characteristics of Inguinal Lymph Nodes and Pelvic Lymph Node Involvement in Penile Squamous Cell Carcinoma: A Single Institution Experience 36
Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer 36
Leydig cell tumor and hyperplasia: a review 36
Imatinib mesylate in chordoma 36
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO 36
Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene 36
Myoid gonadal tumor. Case series, systematic review, and Bayesian analysis 36
News in the classification of WHO 2022 testicular tumours 36
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT 35
Mediastinal germ cell tumors: A narrative review of their traits and aggressiveness features 35
H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma 35
Prostatic metastases from testicular nonseminomatous germ cell cancer: Two case reports and a review of the literature 35
Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center 35
Neoplasie dell'Apparato genitale maschile: Testicolo 34
Neoplasie dell'apparato genitale maschile: Carcinoma del Pene 34
Persistent CD30 Expression by Embryonal Carcinoma in the Treatment Time Course: Prognostic Significance of a Worthwhile Target for Personalized Treatment 34
Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial Carcinoma 34
Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution 34
Totale 4.864
Categoria #
all - tutte 62.052
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.052


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021100 0 0 0 0 0 7 2 0 91 0 0 0
2021/2022101 0 5 2 30 6 2 28 6 3 1 5 13
2022/2023700 351 150 37 4 1 89 11 32 10 6 5 4
2023/2024494 13 27 30 154 21 74 44 35 7 22 15 52
2024/20252.608 396 32 70 44 109 193 280 225 476 447 167 169
2025/20263.142 543 501 565 1.062 435 36 0 0 0 0 0 0
Totale 7.186